Two doses of Covaxin have 50% effectiveness against symptomatic Covid-19, the first real-world assessment of the effectiveness of the vaccine developed in India suggests according to the study published in The Lancet Infectious Diseases journal. pic.twitter.com/NNtOqjfjYR— Prasar Bharati News Services पी.बी.एन.एस. (@PBNS_India) November 24, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


